Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

The interpersonal and intrapersonal diversity of human-associated microbiota in key body sites.

Ursell LK, Clemente JC, Rideout JR, Gevers D, Caporaso JG, Knight R.

J Allergy Clin Immunol. 2012 May;129(5):1204-8. doi: 10.1016/j.jaci.2012.03.010.

2.

Microbiome and skin diseases.

Zeeuwen PL, Kleerebezem M, Timmerman HM, Schalkwijk J.

Curr Opin Allergy Clin Immunol. 2013 Oct;13(5):514-20. doi: 10.1097/ACI.0b013e328364ebeb. Review.

PMID:
23974680
3.

The microbiome in inflammatory bowel disease: current status and the future ahead.

Kostic AD, Xavier RJ, Gevers D.

Gastroenterology. 2014 May;146(6):1489-99. doi: 10.1053/j.gastro.2014.02.009. Review.

4.

Mechanistic links between gut microbial community dynamics, microbial functions and metabolic health.

Ha CW, Lam YY, Holmes AJ.

World J Gastroenterol. 2014 Nov 28;20(44):16498-517. doi: 10.3748/wjg.v20.i44.16498. Review.

5.

Gut matters: microbe-host interactions in allergic diseases.

Hörmannsperger G, Clavel T, Haller D.

J Allergy Clin Immunol. 2012 Jun;129(6):1452-9. doi: 10.1016/j.jaci.2011.12.993. Review.

PMID:
22322009
6.

Application of metagenomics in the human gut microbiome.

Wang WL, Xu SY, Ren ZG, Tao L, Jiang JW, Zheng SS.

World J Gastroenterol. 2015 Jan 21;21(3):803-14. doi: 10.3748/wjg.v21.i3.803. Review.

7.

Intestinal microbiota in health and disease: role of bifidobacteria in gut homeostasis.

Tojo R, Suárez A, Clemente MG, de los Reyes-Gavilán CG, Margolles A, Gueimonde M, Ruas-Madiedo P.

World J Gastroenterol. 2014 Nov 7;20(41):15163-76. doi: 10.3748/wjg.v20.i41.15163. Review.

8.

Microbiota regulation of inflammatory bowel disease.

Evans-Marin HL, Cong Y.

Inflamm Allergy Drug Targets. 2014 Feb;13(1):65-73. Review.

PMID:
24438006
9.

Effect of barrier microbes on organ-based inflammation.

Garn H, Neves JF, Blumberg RS, Renz H.

J Allergy Clin Immunol. 2013 Jun;131(6):1465-78. doi: 10.1016/j.jaci.2013.04.031. Review.

10.

Advances in inflammatory bowel disease pathogenesis: linking host genetics and the microbiome.

Knights D, Lassen KG, Xavier RJ.

Gut. 2013 Oct;62(10):1505-10. doi: 10.1136/gutjnl-2012-303954. Review.

11.

Functional impacts of the intestinal microbiome in the pathogenesis of inflammatory bowel disease.

Li J, Butcher J, Mack D, Stintzi A.

Inflamm Bowel Dis. 2015 Jan;21(1):139-53. doi: 10.1097/MIB.0000000000000215. Review.

PMID:
25248007
12.

Immune homeostasis, dysbiosis and therapeutic modulation of the gut microbiota.

Peterson CT, Sharma V, Elmén L, Peterson SN.

Clin Exp Immunol. 2015 Mar;179(3):363-77. doi: 10.1111/cei.12474. Review.

13.

[Interaction between humans and intestinal bacteria as a determinant for intestinal health : intestinal microbiome and inflammatory bowel diseases].

Haller D, Hörmannsperger G.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2015 Feb;58(2):159-65. doi: 10.1007/s00103-014-2095-0. Review. German.

PMID:
25566836
14.

[The intestinal microbiota and inflammatory bowel disease].

Guarner F.

Gastroenterol Hepatol. 2011 Mar;34(3):147-54. doi: 10.1016/j.gastrohep.2010.11.009. Review. Spanish.

PMID:
21377761
15.

Dysbiotic events in gut microbiota: impact on human health.

Schippa S, Conte MP.

Nutrients. 2014 Dec 11;6(12):5786-805. doi: 10.3390/nu6125786. Review.

16.

Regulation of intestinal homeostasis and immunity with probiotic lactobacilli.

van Baarlen P, Wells JM, Kleerebezem M.

Trends Immunol. 2013 May;34(5):208-15. doi: 10.1016/j.it.2013.01.005. Review.

PMID:
23485516
17.

Negative interactions with the microbiota: IBD.

Salzman NH, Bevins CL.

Adv Exp Med Biol. 2008;635:67-78. doi: 10.1007/978-0-387-09550-9_6. Review.

PMID:
18841704
18.

Regulation of intestinal microbiota by the NLR protein family.

Biswas A, Kobayashi KS.

Int Immunol. 2013 Apr;25(4):207-14. doi: 10.1093/intimm/dxs116. Review.

19.

Microbiota alterations in acute and chronic gastrointestinal inflammation of cats and dogs.

Honneffer JB, Minamoto Y, Suchodolski JS.

World J Gastroenterol. 2014 Nov 28;20(44):16489-97. doi: 10.3748/wjg.v20.i44.16489. Review.

20.

Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.

Tomasello G, Tralongo P, Damiani P, Sinagra E, Di Trapani B, Zeenny MN, Hussein IH, Jurjus A, Leone A.

World J Gastroenterol. 2014 Dec 28;20(48):18121-30. doi: 10.3748/wjg.v20.i48.18121. Review.

Items per page

Supplemental Content

Support Center